Exacerbations Among Patients Receiving Breztri (EROS Study)

Trial Identifier:	D5980R00079
Sponsor:	AstraZeneca
Start Date:	October 2022
Primary Completion Date:	March 2023
Study Completion Date:	March 2023
Condition:	Other; Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, DE	Wilmington, DE, United States, 19850

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.